Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

2.18
Delayed Data
As of 3:11pm ET
 -0.0711 / -3.16%
Today’s Change
1.79
Today|||52-Week Range
7.66
+4.25%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close2.25
Today’s open2.21
Day’s range2.16 - 2.23
Volume49,994
Average volume (3 months)40,990
Market cap$38.7M
Dividend yield--
Data as of 3:11pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)+12.09%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
ACURAcura Pharmaceutical...-0.08-2.44%
NTECIntec Pharma Ltd+0.02+0.59%
ABIOARCA Biopharma Inc-0.08-1.90%
PTNPalatin Technologies...-0.03-5.41%
Data as of 3:17pm ET, 05/02/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers

Search for Jobs